Table 2 Liver function of the BA subjects and the controls
From: Metabolism-related hepatokines change in biliary atresia: ANGPTL6 as a potential biomarker
BA subjects (n = 38) | Controls (n = 12) | P value | |
|---|---|---|---|
Total bilirubin (µmol/L) | 169.2 ± 38.1 | 17.0 ± 12.5 | < 0.001 |
Direct bilirubin (µmol/L) | 93.1 ± 18.4 | 3.9 ± 2.9 | < 0.001 |
Alanine transaminase (U/L) | 156 ± 109 | 36 ± 14 | < 0.001 |
Aspartate transaminase (U/L) | 249 ± 153 | 54 ± 16 | < 0.001 |
gamma glutamyl transpeptidase (U/L) | 534 ± 470 | 67 ± 62 | < 0.001 |
Alkaline phosphatase (U/L) | 621 ± 217 | 346 ± 113 | < 0.001 |
Total bile acids (µmol/L) | 143.7 ± 40.8 | 14.1 ± 6.4 | < 0.001 |